The Türkish Version of the Freezing of Gait Questionnaire

NCT03413787 | Completed

• 1 other identifier: Ordu2
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

The freezing of gait (FOG) is one of the disabling symptoms in Parkinson's disease. The diagnosis and assessment of the FOG may be diffucult, but it is absolutely necessary. The aim of this study was to develop a Türkish version of the freezing of gait questionnaire (FOG-Q) and assess the validity and reliability of this Türkish version. The researchers firstly communicated with the developers of the FOG-Q. The permission for Turkish version was received by Giladi. Then, the FOG-Q will be adapted into Türkish using forward-backward translation by three native Türkish-speaking forward translators and one native English-speaking backward translator. The internal reliability of the FOG-Q Türkish version will be assessed using Cronbach's alpha, and item analyses will be conducted by examining the effect on Cronbach's alpha of excluding each of the six FOG-Q items individually. The test-retest reliability will be assessed using intraclass correlation coefficient (ICC). Convergent validity will be evaluated by means of Spearman rank correlation coefficient (rs). In this section will be determined the correlation between the FOG-Q scores and scores of the UPDRS motor section , Berg Balance Scale, Timed up and go test, Falls Efficacy Scale and Hoehn and Yahr stages.

Conditions

Parkinson Disease; Motor Disorder; Gait Disorders, Neurologic

Outcome Measures

Primary Outcomes (1)

• Türkish version of the Freezing of Gait Questionnaire

  Türkish version of the Freezing of Gait Questionnaire determine the episode of the freezing and the severity of the freezing by six items. Each items with five response categories (scored from 0 to 4) that are summed into a total score (range 0-24; higher scores = more severe FOG).

  5 minutes

Secondary Outcomes (5)

• Unified Parkinson's Disease Rating Scale-part III

  5 minutes

• Berg Balance Scale

  10 minutes

• Timed up and go test

  2 minutes

• Fall Efficacy Scale

  5 minutes

• Hoehn and Yahr Scale

  2 minutes

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

The study population will be selected from neurologic clinic.

You may qualify if:

• a clinical diagnosis of idiopathic PD
• able to walk with or without a walking device

You may not qualify if:

• a diagnosis of other neurological disorders
• any other medical conditions
• not able to take commands.

Sponsors & Collaborators

• Ordu University: lead

Study Sites (1)

Sevim ACARÖZ CANDAN

Ordu, Altinordu, 52100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Parkinson Disease; Motor Disorders; Gait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases; Mental Disorders; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Sevim ACARÖZ CANDAN, PhD

  Ordu University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Head of the Department of Physiotherapy and Rehabilitation

Study Record Dates

• First Submitted: January 22, 2018
• First Posted: January 29, 2018
• Study Start: January 29, 2018
• Primary Completion: February 12, 2018
• Study Completion: February 19, 2018
• Last Updated: March 23, 2018

Record last verified: 2018-03

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)